Show simple item record

dc.contributor.advisorAnna-Liisa Brownell and David Cory.en_US
dc.contributor.authorLamb, Peter (Peter Alexander John)en_US
dc.contributor.otherMassachusetts Institute of Technology. Dept. of Nuclear Science and Engineering.en_US
dc.date.accessioned2009-03-16T19:49:37Z
dc.date.available2009-03-16T19:49:37Z
dc.date.copyright2008en_US
dc.date.issued2008en_US
dc.identifier.urihttp://hdl.handle.net/1721.1/44840
dc.descriptionThesis (S.B.)--Massachusetts Institute of Technology, Dept. of Nuclear Science and Engineering, 2008.en_US
dc.descriptionIncludes bibliographical references (leaves 26-27).en_US
dc.description.abstractMicroPET imaging studies were conducted to investigate the role of metabotropic glutamate subtype-5 receptors (mGluR5) in Parkinson's disease (PD). Four analogical PET ligands were used to characterize modulation of mGluR5 function in a 6hydroxydopamine (6-OHDA) induced rat model of PD. Unilateral 6-OHDA lesions were made in the right medial forebrain bundle, and severity of these lesions was determined with [¹¹]CFT. The binding characteristics of the PET ligands were analyzed using a modified distribution volume method of the Logan reference region model. Binding potential values were calculated on the striatum, hippocampus, and cortex, using the cerebellum as a reference tissue. On the right (with lesion) side of the striatum, ["C]CFT binding decreased. Three of the four investigated mGluR5 ligands ([¹¹C]MPEP, [¹¹C]M-PEPy, and [¹¹C]MMPEP) also showed enhanced binding characteristics on the same side of the brain. The right hippocampus and cortex showed similar results. The mGluR5s' enhanced binding characteristics on the right side of the brain suggest a complementary and compensatory role of metabotropic glutamate receptors in the dopaminergic neurodegeneration of Parkinson's disease.en_US
dc.description.statementofresponsibilityby Peter Lamb.en_US
dc.format.extent27 leavesen_US
dc.language.isoengen_US
dc.publisherMassachusetts Institute of Technologyen_US
dc.rightsM.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission.en_US
dc.rights.urihttp://dspace.mit.edu/handle/1721.1/7582en_US
dc.subjectNuclear Science and Engineering.en_US
dc.titleCharacterizing the modulation of mGluR5 in a 6-OHDA-induced rat model of Parkinson's diseaseen_US
dc.typeThesisen_US
dc.description.degreeS.B.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Nuclear Science and Engineering
dc.identifier.oclc301587846en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record